Answers are grounded in this paper and cite their sources.
Comprehensive analysis reveals resistance training enhances glycemic control and muscle strength in T2D patients, suggesting important clinical implications.
Type 2 diabetes (T2D) is a global pandemic imposing substantial health and economic burdens, highlighting the critical need for effective non-pharmacological management strategies beyond medication. This paper comprehensively examines the biological mechanisms underpinning the therapeutic effects of resistance training (RT) in T2D and translates this evidence into clinical applications. The results of this paper demonstrate that RT enhances glycemic control by upregulating skeletal muscle GLUT4 expression through AMPK/HDAC5-MEF2 and Akt/AS160 pathways, and activates mTORC1 signaling to promote protein anabolism. Clinically, structured RT significantly reduces HbA1c, attenuates postprandial glucose fluctuations, and mitigates major complications. The rationale is to improve the prognosis of diabetic foot by enhancing plantar pressure distribution and endothelial function, which is expected to reduce renal inflammation and oxidative stress in a preclinical diabetic nephropathy model, and in combination with aerobic exercise, improve nerve conduction velocity and pain in diabetic peripheral neuropathy. Critically, RT demonstrates a unique "strength-metabolism coupling" effect, concurrently improving muscle strength and glycemic control, especially in elderly T2D patients with sarcopenia. This paper underscores RT as a potent, evidence-based cornerstone intervention for T2D management. It provides a crucial theoretical foundation for developing personalized RT prescriptions and integrating RT within multidisciplinary care models to optimize outcomes and reduce complication risks.
No takes yet. Share an insight, caveat, or question.
Z Wu (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: